Marinus Pharmaceuticals News

Marinus Pharma Analyst Ratings

BenzingaOct 26 03:12

Marinus Pharmaceuticals Price Target Cut to $1.00/Share From $3.00 by RBC Capital

Dow JonesOct 26 01:38

Cantor Fitzgerald Maintains Overweight on Marinus Pharma, Lowers Price Target to $4

BenzingaOct 26 00:16

Oppenheimer Maintains Marinus Pharmaceuticals(MRNS.US) With Buy Rating

Futu NewsOct 25 21:31

A Quick Look at Today's Ratings for Marinus Pharmaceuticals(MRNS.US), With a Forecast Between $3 to $3

Futu NewsOct 25 21:09

Marinus Downgraded After Setback to Late-stage Trial

Seeking AlphaOct 25 21:06

Marinus (MRNS) Receives a Hold From RBC Capital

TipRanksOct 25 20:03

HC Wainwright Downgrades Marinus Pharmaceuticals to Neutral From Buy, Adjusts Price Target to $2 From $11

MT NewswiresOct 25 18:32

Marinus Pharmaceuticals Cut to Market Perform From Market Outperform by JMP Securities

Dow JonesOct 25 02:54

EF Hutton Maintains Buy on Marinus Pharma, Lowers Price Target to $3

BenzingaOct 24 21:49

Marinus Pharma Analyst Ratings

BenzingaOct 24 21:48

Marinus Pharma Analyst Ratings

BenzingaOct 12 02:15

EF Hutton Initiates Coverage On Marinus Pharma With Buy Rating, Announces Price Target of $23

BenzingaOct 1 00:14

JMP Securities Reiterates Market Outperform on Marinus Pharma, Maintains $10 Price Target

BenzingaSep 23 21:07

A Quick Look at Today's Ratings for Marinus Pharmaceuticals(MRNS.US), With a Forecast Between $6 to $10

Futu NewsSep 23 21:00

Marinus Pharma Analyst Ratings

BenzingaSep 17 00:20

Truist Financial Maintains Marinus Pharmaceuticals(MRNS.US) With Buy Rating

Futu NewsSep 16 19:31

Marinus Pharmaceuticals Price Target Maintained With a $13.00/Share by Cantor Fitzgerald

Dow JonesSep 9 23:59

Cautious Optimism Amidst Clinical Uncertainties: A Hold Rating for Marinus Pharmaceuticals

TipRanksAug 16 14:32

A Quick Look at Today's Ratings for Marinus Pharmaceuticals(MRNS.US), With a Forecast Between $11 to $11

Futu NewsAug 15 21:00